This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Inserm (Institute National De La Santa Et De La Recherche Medicale), Instiut Pasteur De Lille. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Yoann Sottejeau: Innovator in Aortic Valve Calcification Research
Introduction
Yoann Sottejeau is a notable inventor based in Lille, France. He has made significant contributions to the field of medical research, particularly in understanding and addressing aortic valve calcification. His innovative work has led to the development of a patent that holds promise for improving heart health.
Latest Patents
Yoann Sottejeau holds a patent for the "Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve." Aortic valve calcification is a condition characterized by calcium deposits forming on the aortic valve, which can lead to severe narrowing and reduced blood flow, known as aortic valve stenosis. His research demonstrates that retinoic acid can decrease calcification and the osteoblast-like phenotype in valvular interstitial cells (VICs). More specifically, RARα activation has been shown to reduce calcification and the osteoblast-like phenotype in VICs, while ALDH1A1 inhibition increases these conditions. This groundbreaking work suggests that RAR agonists could be effective in reversing, preventing, or delaying aortic valve calcification.
Career Highlights
Throughout his career, Yoann Sottejeau has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Lille. His research has focused on innovative solutions to complex medical issues, particularly those affecting cardiovascular health.
Collaborations
Yoann has collaborated with notable colleagues, including Sophie Susen and Delphine Corseaux. These partnerships have contributed to the advancement of his research and the development of his patent.
Conclusion
In summary, Yoann Sottejeau is a pioneering inventor whose work on aortic valve calcification has the potential to transform treatment options in cardiology. His innovative approach and dedication to research continue to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile